ATE90690T1 - Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. - Google Patents

Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.

Info

Publication number
ATE90690T1
ATE90690T1 AT88904042T AT88904042T ATE90690T1 AT E90690 T1 ATE90690 T1 AT E90690T1 AT 88904042 T AT88904042 T AT 88904042T AT 88904042 T AT88904042 T AT 88904042T AT E90690 T1 ATE90690 T1 AT E90690T1
Authority
AT
Austria
Prior art keywords
carrier protein
protein subunits
production
methods
human
Prior art date
Application number
AT88904042T
Other languages
English (en)
Inventor
Emerald Martin Spencer
Original Assignee
Celtrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharma filed Critical Celtrix Pharma
Application granted granted Critical
Publication of ATE90690T1 publication Critical patent/ATE90690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88904042T 1987-04-06 1988-03-31 Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. ATE90690T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06
PCT/US1988/001042 WO1988007863A1 (en) 1987-04-06 1988-03-31 Human somatomedin carrier protein subunits and process for producing them
EP88904042A EP0308500B1 (de) 1987-04-06 1988-03-31 Menschliche somatomedin-träger-protein-untereinheiten und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ATE90690T1 true ATE90690T1 (de) 1993-07-15

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904042T ATE90690T1 (de) 1987-04-06 1988-03-31 Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.

Country Status (11)

Country Link
EP (2) EP0308500B1 (de)
JP (1) JP2648951B2 (de)
AT (1) ATE90690T1 (de)
AU (1) AU627423B2 (de)
CA (1) CA1340295C (de)
DE (1) DE3881801T2 (de)
DK (1) DK677688D0 (de)
ES (1) ES2058341T3 (de)
IL (1) IL85983A (de)
WO (1) WO1988007863A1 (de)
ZA (1) ZA882407B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
EP0424416B1 (de) * 1988-07-15 1995-07-19 Central Sydney Area Health Service Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
RU2126683C1 (ru) * 1992-12-17 1999-02-27 Товарищество с ограниченной ответственностью "САМИ" Способ получения антисоматотропной сыворотки
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
DE60042550D1 (de) 1999-01-06 2009-08-27 Genentech Inc Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
ES2301547T3 (es) 2000-05-16 2008-07-01 Genentech, Inc. Tratamiento de trastornos del cartilago.
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
WO2005016970A2 (en) 2003-05-01 2005-02-24 Imclone Systems Incorporated Fully human antibodies directed against the human insulin-like growth factor-1 receptor
ATE536186T1 (de) 2003-09-12 2011-12-15 Tercica Inc Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel
EP1670822A2 (de) 2003-10-03 2006-06-21 Genentech, Inc. Igf-bindende proteine
PT2100618E (pt) 2005-06-17 2014-04-07 Philadelphia Health & Educatio Um anticorpo anti-pdgfr-alfa para o tratamento de cancro ósseo metastático
AU2007212447B2 (en) 2006-02-03 2013-02-21 Imclone Llc IGF-IR antagonists as adjuvants for treatment of prostate cancer
WO2019051474A1 (en) 2017-09-11 2019-03-14 Shire Human Genetic Therapies, Inc. METHODS AND COMPOSITIONS FOR TREATING CHRONIC PULMONARY DISEASES
JP7827315B2 (ja) 2020-10-19 2026-03-10 オーク ヒル バイオ リミテッド 新生児における使用に好適な組成物
AU2023210427A1 (en) 2022-01-19 2024-08-22 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
EP4665383A1 (de) 2023-02-14 2025-12-24 Oak Hill Bio Limited Behandlung von heilungsdysregulation in gi-gewebe

Also Published As

Publication number Publication date
ZA882407B (en) 1988-09-28
DE3881801T2 (de) 1993-12-23
IL85983A0 (en) 1988-09-30
AU627423B2 (en) 1992-08-27
EP0294021A1 (de) 1988-12-07
JP2648951B2 (ja) 1997-09-03
CA1340295C (en) 1998-12-29
DE3881801D1 (de) 1993-07-22
AU1702088A (en) 1988-11-04
DK677688A (da) 1988-12-05
EP0308500A1 (de) 1989-03-29
DK677688D0 (da) 1988-12-05
ES2058341T3 (es) 1994-11-01
JPH01502986A (ja) 1989-10-12
EP0308500B1 (de) 1993-06-16
WO1988007863A1 (en) 1988-10-20
IL85983A (en) 1994-10-07

Similar Documents

Publication Publication Date Title
ATE90690T1 (de) Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
ZA899832B (en) Human somatomedin carrier protein subunits and process for producing them;recombinant dna molecules,hosts,processes and human somatomedian carrier protein-like polypeptides
DK564989A (da) Bindingsproteiner
DE69130113D1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
DE3882055D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeure-verbindungen.
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
FI97299C (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
FI953525L (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
DE3853033D1 (de) Verfahren zur Herstellung von stabilisierten Zeolithkatalysatoren.
DE69319012D1 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
DE69327059D1 (de) Verfahren zur herstellung von testelementen
AU576508B2 (en) Sythetic peptides antigenically corresponding to brain specific proteinoids
HUT55800A (en) Process for producing anticoagulant peptides
ATE127478T1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
DE68929429D1 (de) Verfahren zur Herstellung von Pyridin-2,3-Dicarbonsäure-Verbindungen
ATE27159T1 (de) Carbapenamverbindung und verfahren zu ihrer herstellung.
DE3771799D1 (de) Verfahren zur herstellung von heterozyklen durch palladium-zyklische komplexe.